Patent Application
20150087960
The present general inventive concept relates to Positron Emission Tomography (PET), and more particularly to utilizing PET to assist proton beam therapy (PT) by dynamic target tracking during radiation treatment.
Radiation used for cancer treatment is called ionizing radiation because it forms ions (electrically charged particles) in the cells of the tissues it passes through. It creates ions by removing electrons from atoms and molecules. This can kill cells or change genes so the cells cannot grow. The ideal radiation with which to treat cancer is one that delivers a defined dose distribution within the target volume and none outside it in order to maximize the dose to the tumor and minimize the dose to surrounding normal tissue.
Ionizing radiation may be sorted into 2 major types: photons (e.g. x-rays and gamma rays), which are most widely used and particle radiation (e.g. electrons, protons, neutrons, carbon ions, alpha particles, and beta particles).
Proton beams (proton beam therapy (PT or PBT)) are an exemplary form of particle beam radiation. Protons are positively charged parts of atoms which cause little damage to tissues they pass through but are very good at killing cells at the end of their path. This means that proton beams may be able to deliver more radiation to the cancer while causing fewer side effects to normal tissues.
For protons and heavier ions, however, the dose increases because the particle penetrates the tissue and loses energy continuously. Hence the dose increases with increasing thickness up to a Bragg peak that occurs near the end of the particle's range. Beyond the Bragg peak, the dose drops to zero (for protons) or almost zero (for heavier ions). The advantage of this energy deposition profile is that less energy is deposited into the healthy tissue surrounding target tissue. Ions are accelerated by means of a cyclotron or synchrotron. The final energy of the emerging particle beam defines the depth of penetration, and hence, the location of the maximum energy deposition. Since it is easy to deflect the beam by means of electro-magnets in a transverse direction, it is possible to employ a raster scan method, i.e., to scan a target area quickly. If the depth of penetration is varied, an entire target volume can be covered in three dimensions, providing an irradiation following the shape of a tumor.
Positron emission tomography (PET) is a nuclear medical imaging technique that produces an image or picture of functional processes in a body. The system detects pairs of gamma rays emitted indirectly by a positron-emitting radionuclide (tracer, radiotracer, radiopharmaceutical, etc.), which is introduced into the body on a biologically active molecule. A radionuclide, or a radioactive nuclide, is an atom with an unstable nucleus, characterized by excess energy available to be imparted either to a newly created radiation particle within the nucleus or via internal conversion. During this process, the radionuclide is said to undergo radioactive decay, resulting in the emission of gamma ray(s) and/or subatomic particles such as alpha or beta particles. These emissions constitute ionizing radiation. Radionuclides are often referred to as radioactive isotopes or radioisotopes.
As the radioisotope undergoes positron emission decay (also known as positive beta decay), it emits a positron, an antiparticle of the electron with opposite charge. The emitted positron travels in tissue for a short distance (typically less than 1 mm, dependent on the isotope), during which time it loses kinetic energy, until it decelerates to a point where it can interact with an electron. The encounter annihilates both electron and positron, producing a pair of annihilation (gamma) photons moving in approximately opposite directions. These are detected when they reach a scintillator in a scanning device, creating a burst of light which is detected by photomultiplier tubes, silicon avalanche photodiodes (Si APD), or silicon photomultipliers (Si PM).
Three-dimensional distribution of radionuclide concentration within the body may be constructed by computer analysis in the PET process.
Efforts regarding positron emission tomography and proton therapy have led to continuing developments to improve their versatility, practicality and efficiency.
Example embodiments of the present general inventive concept can be achieved by providing a proton delivery guidance system for use with a proton treatment system, the proton treatment system having a proton delivery nozzle to direct protons to a target area of a patient, the proton delivery guidance system including a positron emission tomography (PET) system having a detector unit to scan for radiotracers introduced into a patient's body, the PET system including a processing unit to generate location information of an image corresponding to a target area of the patient, and a guidance unit to receive the location information from the PET system and to instruct the proton treatment system to direct protons to the target area according to the location information.
The detector unit can include a partial ring-shape having an opening therein, and the guidance unit can include a motion control unit configured to control movement of the detector unit such that the proton delivery nozzle directs protons to the target area through the opening while the detector unit scans for radiotracers in the patient's body.
The PET system can be a combined PET/computed tomography (CT) or PET/magnetic resonance imaging (MRI) system.
The detector unit can be a time-of-flight capable detector unit, and the processing unit can utilize limited angle tomographic reconstruction to compensate for incomplete sampling and to estimate radiotracer distribution within the patient's body.
The proton treatment system can include a gantry wheel to rotate the proton treatment nozzle around the patient, and the motion control unit can be configured to control rotation of the gantry wheel according to the location information.
Example embodiments of the present general inventive concept can also be achieved by providing a proton therapy (PT) treatment system, including a positron emission tomography (PET) system to scan for radiotracers in a patient, a processor to determine concentrations of the radiotracers in a target area of the patient and to provide radiotracer location data, a proton beam delivery unit to direct protons to the target area, and a guidance system to control the proton beam delivery unit to direct protons to the target area utilizing the radiotracer location data.
The PET system can scan for radiotracers simultaneously while the proton beam delivery unit directs protons to the targeted area. This can be done in real-time.
The processor can utilize a dynamic tumor tracking algorithm to provide the radiotracer location data.
The proton beam delivery unit can be configured to direct protons of different energies with different Bragg peaks at different depths to the target area.
Example embodiments of the present general inventive concept can also be achieved by providing a method of treating a patient using proton beam therapy (PT), including injecting a patient with one or more radiotracers, scanning for at least one of the radiotracers utilizing positron emission tomography (PET), locating concentrations of the at least one radiotracer in a target area of a patient, generating radiotracer location data of the target area, and radiating the patient with proton beam therapy (PT) utilizing the radiotracer location data, wherein the locating and radiating operations are performed simultaneously in real-time.
The locating operation may include utilizing a dynamic tumor tracking algorithm.
Protons of different energies with different Bragg peaks at different depths can be applied in the PT.
The PET can utilize a compound labeled with a positron emitting radionuclide which localizes in the target tumor, such as [18F] flourodeoxyglucose.
Example embodiments of the present general inventive concept can also be achieved by providing a proton treatment system having a proton delivery unit to direct protons to a target area of a patient, the proton treatment system including a positron emission tomography (PET) system having a detector unit to scan for radiotracers introduced into a patient's body, a processing unit to generate location information corresponding to a target area of the patient based on a scanned radiotracer, and a guidance unit to receive the location information from the PET system and to instruct the proton delivery unit to direct protons to the target area according to the location information.
The detector unit can include a partial ring-shape having an opening therein. The proton delivery unit can include a gantry wheel to rotate a proton delivery nozzle around the patient. The guidance unit can include a motion control unit to control movement of the detector unit and the gantry wheel such that the proton delivery nozzle directs protons to the target area through the opening while the detector unit scans for radiotracers in the patient's body.
Additional features and embodiments of the present general inventive concept will be set forth in part in the description which follows, and may be obvious from the description, or may be learned by practice of the present general inventive concept.
The following example embodiments are representative of example techniques and structures designed to carry out objectives of the present general inventive concept, but the present general inventive concept is not limited to these example embodiments. In the accompanying drawings and illustrations, the sizes and relative sizes, shapes, and qualities of lines, entities, and regions may be exaggerated for clarity. A wide variety of additional embodiments will be more readily understood and appreciated through the following detailed description of the example embodiments, with reference to the accompanying drawings in which:
Reference will now be made to the example embodiments of the present general inventive concept, examples of which are illustrated in the accompanying drawings and illustrations. The example embodiments are described herein in order to explain the present general concept by referring to the figures.
The gantry system 10 may include a mezzanine platform 12 support system and moving (or rolling) floor 210 for a technician or operator to walk on, enabling access to a patient, magnets, nozzles, achromat, hoses from a beamline, cooling system, etc. for service or replacement. The moving floor may be supported by a moving floor system 200.
An example embodiment moving floor system 200 provides a moving platform 210 on which an operator 44 may stand on, the floor moving in directions indicated by arrows 50a, 50b. The moving floor 210 may have an opening 220 provided therein for providing clearance for the proton beam nozzle apparatus 34 when the beam nozzle is rotated underneath the patient below the floor 220. As the beam nozzle 34 rotates around the patient, it is possible to provide the opening 220 to allow the nozzle 34 to protrude through the opening when at least a portion of the nozzle is rotated below the floor.
In an example embodiment, the PET may be utilized to produce tomographic images of specific areas of the body. A partial ring detector geometry can allow for the acquisition of data during proton beam delivery. Time of flight (TOF) capable detectors and limited angle tomographic reconstruction techniques can be used to compensate for incomplete sampling and for estimation of the three-dimensional radionuclide distribution within the body. Daily volumetric (e.g. cone-beam CT) x-ray imaging information, planning CT images and structures identified during treatment planning are incorporated in the data processing to identify PET data associated with the target tumor volume (and compensate for attenuation of PET within the body).
Referring to
In an example embodiment, a processor programmed PET dynamic tumor tracking algorithm may be utilized to estimate target position information utilizing the tumor center of mass (CoM) of segmented target volume on gated PET images which are continuously updated throughout a scan.
In an example embodiment, the PET nuclear medical imaging technique produces a three-dimensional image or picture of the body by detecting pairs of gamma rays emitted indirectly by a positron-emitting radionuclide (tracer) introduced into the body on a biologically active molecule. Three-dimensional images of tracer concentration within the body may then be constructed by computer or processor analysis.
Referring to
In an example embodiment, three dimensional imaging may be accomplished with the aid of a CT X-ray scan or magnetic resonance imaging (MRI) scan performed on the patient during the same session, in the same machine.
In an example embodiment, the biologically active molecule chosen for the PET is fluorodeoxyglucose (FDG), wherein the concentrations of radiotracer imaged will indicate tissue metabolic activity by virtue of regional glucose uptake. Other radiotracers may be used in the PET to image the tissue concentration of other types of molecules of interest.
In an example embodiment, the PET system utilizes a [18F] labeled radiotracer.
In an example embodiment, protons of different energies with Bragg peaks at different depths are applied in the PT process.
In an example embodiment, a method of treating a patient includes: injecting a patient with radiotracers; scanning for the radiotracers utilizing positron emission tomography (PET); locating concentrations of the radiotracers in a target area and providing radiotracer location data; radiating the patient with proton beam therapy (PT) utilizing the radiotracer location data, wherein the locating and radiating are performed in real-time. The method may include utilizing a dynamic tumor tracking algorithm. The method may include utilizing protons of different energies with Bragg peaks at different depths are applied in the PT.
In an example embodiment, a system for treating a patient includes: a positron emission tomography (PET) for scanning for radiotracers in the patient; a processor for determining concentrations of the radiotracers in a target area and providing radiotracer location data; a proton beam therapy (PT) system for radiating the patient utilizing the radiotracer location data; wherein the determining and radiating are performed in real-time. The system may include utilizing a dynamic tumor tracking algorithm. The system may include utilizing protons of different energies with Bragg peaks at different depths are applied in the radiating.
While the present general inventive concept has been described in relation to certain example embodiments in detail, it is not the intention of the applicant to restrict or in any way limit the scope of the appended claims to such detail. Additional modifications may readily appear to those skilled in the art. The claimed subject matter in its broader aspects is therefore not limited to the specific details, representative apparatus and methods, and illustrative examples shown and described. Accordingly, departures may be made from such details without departing from the spirit or scope of applicant's general concept.
This application claims the benefit of U.S. Provisional Patent Application Ser. No. 61/880,559, filed on Sep. 20, 2013, the disclosure of which is incorporated herein in its entirety by reference.
| Number | Date | Country | |
|---|---|---|---|
| 61880559 | Sep 2013 | US |
